Bone Health Awareness Sale ends in 00days 00hrs 00min
← Learn

Why Fat Shifts to Your Midsection After Menopause: What the Research Shows

July 30, 2026 · Optimum Research Team
Why Fat Shifts to Your Midsection After Menopause: What the Research Shows

A 2008 longitudinal study tracked women through the menopause transition and found visceral fat rose while daily energy expenditure fell, in some women with very little change on the scale. That shift is driven largely by estrogen, which normally helps direct where the body stores fat. In 2025, a double-blind trial tested a shilajit-containing formula directly against that shift and measured modest but real improvements in body composition and insulin sensitivity. Here is the mechanism behind why this happens, and an honest look at what that trial actually found.

Why does fat move to your midsection, even if the scale barely moves?

Why does fat move to your midsection, even if the scale barely moves?

It is one of the more disorienting parts of menopause. Your weight on the scale has not changed dramatically, your eating has not changed, and yet your waistbands fit differently than they did 5 years ago.

That experience has real measurement behind it. A 2008 study published in the International Journal of Obesity followed women through the menopause transition and tracked body composition directly, rather than relying on weight alone.

Here is what that study actually found.

  • Visceral fat area increased through the transition
  • Subcutaneous fat, the kind under the skin at the hips and thighs, changed far less
  • Resting energy expenditure fell
  • Total body weight, in many participants, barely moved at all

Weight on a scale was never the whole story. Where fat is stored, and how many calories your body burns at rest, both shifted underneath a number that looked mostly the same.

What actually controls where your body stores fat?

What actually controls where your body stores fat?

Fat storage is not random. It is directed.

The receptors doing the directing

Fat tissue itself carries estrogen receptors, largely a subtype called ERα. A 2014 review in BioMed Research International laid out the mechanism. Estrogen acting on those receptors favors storing fat in the hips and thighs and limits how much builds up around the abdomen and organs. Animal research has shown the same pattern directly. In one mouse study, estrogen supplementation reduced abdominal fat and protected against impaired glucose tolerance, while its absence reversed both effects.

What happens when the signal falls

At menopause, that signal weakens. Here is what estrogen was doing with fat storage before that shift.

  • Favoring subcutaneous storage at the hips and thighs over visceral storage
  • Limiting fat accumulation around the abdomen and internal organs
  • Supporting a higher resting metabolic rate
  • Regulating how individual fat cells behave, through direct receptor activity

When estrogen signaling falls, none of those 4 things happen as reliably. The Lovejoy 2008 study is the human evidence that this plays out over real time, in real women, not just in a lab model.

What did the shilajit trial actually measure?

What did the shilajit trial actually measure?

This is the part where precision matters most, so we are going to be exact about what was tested and what was not.

In 2025, researchers ran a double-blind, placebo-controlled trial with 166 women enrolled and 109 completers. The formula combined chromium, Phyllanthus emblica, and shilajit, given alongside diet and exercise guidance rather than in place of it.

Shilajit was one of 3 active ingredients in that formula, not tested in isolation. That distinction matters and we are not going to blur it.

Here is what the trial measured across the combination group.

  • Vascular function
  • Insulin sensitivity
  • Lipid levels
  • Body composition

Across those measures, the combination group showed modest improvements compared to placebo. On the lipid side specifically, that result lines up with a separate, shilajit-only trial. A 12-week study in type 2 diabetics found shilajit alone lowered LDL cholesterol by 13 percent, total cholesterol by 21 percent, and triglycerides by 16 percent, while raising HDL by 14 percent.

2 different trials, 2 different designs, pointing at the same lipid mechanism from different angles.

Is this the same thing as a weight loss claim?

No. We want to be direct about that before anything else.

Here is what the 2025 trial actually supports, next to what it does not.

What the trial showed What it did not show
Modest improvements in body composition markers A specific number of pounds or inches lost
A combination formula, with diet and exercise Isolated shilajit tested alone
Statistically measured shifts across 109 completers A large-scale, standalone confirmatory trial
Support for the estrogen-fat-storage mechanism above A hormone-replacement or weight-loss product claim

The honest, useful takeaway is the mechanism, not a promise. Fat storage shifts after menopause because a specific signal weakens. Understanding that is different from being handed a number on a scale.

Is shilajit safe to take alongside diet and exercise changes?

Is shilajit safe to take alongside diet and exercise changes?

In the 2025 trial, the combination formula was well tolerated over the study period. Across every human clinical study ever conducted on shilajit specifically, zero serious adverse events have been reported.

Purity is worth naming on its own, separate from efficacy.

  • All 4 heavy metals tested on every batch, well below USP limits
  • Fulvic acid content verified by an accredited third-party lab
  • A published certificate of analysis you can actually read

Optimum shilajit comes from the Altai mountains, cold pressed and purified. We are a small, family owned company out of Florida, and a real person answers when you reach out. It comes as a box of tablets, not a loose powder that loses its fulvic acid before it reaches you.

This article is educational, not medical guidance for your individual history.

Common questions about body composition after menopause

Does shilajit cause weight loss?

No, and this article is not going to claim that. There is no trial showing isolated shilajit causes weight loss. A 2025 double-blind trial tested a combination formula that included shilajit, alongside diet and exercise, and found modest improvements in body composition and insulin sensitivity. That is meaningfully different from a standalone weight-loss claim, and we want that distinction stated plainly.

Why does fat move to the midsection after menopause even if my weight hasn't changed much?

Estrogen normally favors storing fat in the hips and thighs and limits how much accumulates around the abdomen. A 2008 longitudinal study found that as women moved through the menopause transition, visceral fat area rose and resting energy expenditure fell, in some cases with very little change in total body weight. It is a shift in location and metabolic rate, not just a shift in pounds.

What did the 2025 shilajit trial actually test?

A double-blind, placebo-controlled trial with 166 women enrolled and 109 completers tested a formula combining chromium, Phyllanthus emblica, and shilajit, taken alongside diet and exercise guidance. Researchers measured vascular function, insulin sensitivity, lipids, and body composition. Shilajit was one of 3 active ingredients, not tested alone, and the improvements were described as modest.

Is shilajit a hormone replacement for estrogen's role in fat storage?

No. Shilajit is not a hormone and does not add estrogen to the body. The research points to it supporting the body's own signaling and metabolic processes rather than replacing a hormone directly. This is mechanism-level, supportive research, not a hormone-replacement claim.

Is shilajit safe to take alongside a diet and exercise plan?

In the 2025 trial, the combination formula was well tolerated. Across every human clinical study ever conducted on shilajit specifically, zero serious adverse events have been reported. This article is educational, not medical guidance for your individual history.

Optimum Shilajit box

Optimum Shilajit, tested in full

If you want a food-form source of the trace minerals and fulvic acid behind the metabolic research above, sourced from the Altai mountains and tested for purity on every batch, here is .

See Optimum Shilajit

Sources

  1. Lovejoy JC, Champagne CM, de Jonge L, et al. Increased visceral fat and decreased energy expenditure during the menopausal transition. International Journal of Obesity. 2008;32:949-958. https://pubmed.ncbi.nlm.nih.gov/18332882/
  2. Lizcano F, Guzman G. Estrogen deficiency and the origin of obesity during menopause. BioMed Research International. 2014. https://pubmed.ncbi.nlm.nih.gov/24734243/
  3. Stubbins RE, Holcomb VB, Hong J, Nunez NP. Estrogen modulates abdominal adiposity and protects female mice from obesity and impaired glucose tolerance. European Journal of Nutrition. 2012;51:861-870. https://doi.org/10.1007/s00394-011-0266-4
  4. Martinez, et al. Double-blind randomized controlled trial of a chromium, Phyllanthus emblica, and shilajit formula with diet and exercise on cardiometabolic markers. 2025. https://pubmed.ncbi.nlm.nih.gov/40573153/
  5. Niranjan A, et al. Shilajit cardiovascular and lipid effects in type 2 diabetics, 12-week trial. 2016. https://ijapr.in/index.php/ijapr/article/view/322
  6. Velmurugan V, et al. 91-day rat toxicology study of black shilajit. 2012. https://pmc.ncbi.nlm.nih.gov/articles/PMC3609271/